Yuying Wang

State Key Laboratory Of Respiratory Health And Multimorbidity
Chengdu, 610041, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

A Dichloropropionamide-Substituted Diaminopyrimidine EGFR-TKI Overcomes Osimertinib Resistance in NSCLC via Dual Anchoring at Ser797 and Met793.

A Dichloropropionamide-Substituted Diaminopyrimidine EGFR-TKI Overcomes Osimertinib Resistance in NSCLC via Dual Anchoring at Ser797 and Met793.

Journal: Journal of medicinal chemistry

Published: December 22, 2025

α-Ketoglutarate accelerates cutaneous wound healing through modulating the epithelial-fibroblast niche.

α-Ketoglutarate accelerates cutaneous wound healing through modulating the epithelial-fibroblast niche.

Journal: JCI insight

Published: October 28, 2025

Acquired resistance to immunotherapy by physical barriers with cancer cell-expressing collagens in non-small cell lung cancer.

Acquired resistance to immunotherapy by physical barriers with cancer cell-expressing collagens in non-small cell lung cancer.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: June 11, 2025

A blood-brain barrier-like vascular gate limits immunotherapy efficacy in neuroendocrine cancers.

A blood-brain barrier-like vascular gate limits immunotherapy efficacy in neuroendocrine cancers.

Journal: Cell

Published: May 28, 2025

Design, synthesis and biological evaluation of 3-arylisoquinoline derivatives as topoisomerase IIα inhibitors for the therapy of small cell lung cancer.

Design, synthesis and biological evaluation of 3-arylisoquinoline derivatives as topoisomerase IIα inhibitors for the therapy of small cell lung cancer.

Journal: Bioorganic & medicinal chemistry

Published: April 27, 2025

Synthesis, Structural Modification, and Antismall Cell Lung Cancer Activity of 3-Arylisoquinolines with Dual Inhibitory Activity on Topoisomerase I and II.

Synthesis, Structural Modification, and Antismall Cell Lung Cancer Activity of 3-Arylisoquinolines with Dual Inhibitory Activity on Topoisomerase I and II.

Journal: Journal of medicinal chemistry

Published: January 23, 2025

Insights into the itaconate family: Immunomodulatory mechanisms and therapeutic potentials.

Insights into the itaconate family: Immunomodulatory mechanisms and therapeutic potentials.

Journal: European journal of pharmacology

Published: November 09, 2024

Acquired semi-squamatization during chemotherapy suggests differentiation as a therapeutic strategy for bladder cancer.

Acquired semi-squamatization during chemotherapy suggests differentiation as a therapeutic strategy for bladder cancer.

Journal: Cancer cell

Published: January 05, 2022

KMT2C deficiency promotes small cell lung cancer metastasis through DNMT3A-mediated epigenetic reprogramming.

KMT2C deficiency promotes small cell lung cancer metastasis through DNMT3A-mediated epigenetic reprogramming.

Journal: Nature cancer

Published: June 23, 2021

Showing 1-9 of 9

Last Updated: 09/26/2026